Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR‑mutant lung cancer with HIF‑1α/TGF‑α expressionKazuya Nishii, Katsuyuki Kiura|Oncology Letters|2021Cited by 4
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Nobuhiko Seki, Kiichiro Ninomiya et al.|Therapeutic Advances in Medical Oncology|2025Cited by 3